| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.0446159312763235 | 0.37586156 |
| NSC 726768 | 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline | 0.0446159312763235 | 0.022666858 |
| NSC 728220 | 1-(3-Bromo-phenyl)-3-(pyridin-2-ylsulfanyl)-propenone | 0.0446159312763235 | 0.043329211 |
| NSC 732837 | 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene | 0.0446159312763235 | 0.10524586 |
| NSC 734977 | Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate | 0.0446159312763235 | 0.131483 |
| NSC 759216 | (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone | 0.0446159312763235 | -0.062392692 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0446159312763235 | 0.46030555 |
| NSC 626108 | Null | 0.0459335986102865 | 0.2688312 |
| NSC 658103 | Null | 0.0459335986102865 | -0.15917772 |
| NSC 679586 | Peridinin | 0.0459335986102865 | 0.011863547 |